Table 1.
Library Type | Provider | No. of Compounds | Screening Method | Screening Format |
No. of Hits |
---|---|---|---|---|---|
Kinase-targeted | Uni Copenhagen Biomol SelleckChem Vitas-M |
4200 160 190 1000 |
TSA TSA, FP TSA, FP FP |
384- 384- 384- 1536- |
4 5 1 0 |
Nucleotide/ nucleoside analogs |
Otava | 960 | TSA, FP | 384- | 22 |
Clinical bioactives | NIH | 740 | TSA, FP | 384- | 2 |
Known drugs | Prestwick | 1200 | FP | 1536- | 3 |
Fragments | Org Pharm Chem | 500 | FP | 1536- | 1 |
Natural derivatives | Timtec Analyticon |
3000 1000 |
FP FP |
1536- 1536- |
0 0 |
Diverse | Enamine MayBridge Elite Synergy Specs ChemBridge |
28,200 14,400 2300 1900 30,300 17,500 |
FP FP FP FP FP FP |
1536- 1536- 1536- 1536- 1536- 1536- |
3 9 0 0 3 2 |
SUM: | 107,600 | 55 |